Rosetta, Warnex sign Canadian distribution deal

08/10/2009 | American City Business Journals

Rosetta Genomics has chosen Warnex Medical Laboratories to be the exclusive distributor in Canada of three of its molecular diagnostic tests for measuring microRNA biomarker expression levels in tumor samples. "Canada is an important market, and this agreement is a significant step as we expand the market for our products in North America," a Rosetta Genomics official said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park